Efficacy and safety of intramuscular administration of tixagevimab–cilgavimab for early outpatient treatment of COVID-19 (TACKLE): a phase 3, randomised, double-blind, placebo-controlled trial

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

The Lancet Respiratory Medicine

Topics

Medicine

Epidemiology

Pathology

Internal Medicine

Infectious Diseases

Show all topics

DOI

10.1016/s2213-2600(22)00180-1

Other Formats

PDF